ITGAM and myasthenia gravis: The full antibody panel is described in Supplementary Table 3. To better understand the effect of CSF1Ri, we compared brain myeloid cells (CD45+ CD11b+) from mice treated with either BU alone, BU + PLX as well as naïve MG and disease MG from a neuropathic LSD characterized by microgliosis (Disease-MG)81,82.